
LTRN
Healthcare · Biotechnology · $6.5M market cap
$0.4331-0.03 (-6.0%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +7.9% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 11, 2026 | Before the open | -0.38 | — | — |
| Aug 14, 2026 | Before the open | -0.38 | -0.28 | +26.3% |
| May 15, 2026 | After the close | -0.36 | -0.30 | +16.7% |
| Nov 12, 2025 | After the close | -0.47 | -0.39 | +17.0% |
| Aug 13, 2025 | After the close | -0.48 | -0.40 | +16.7% |
| May 15, 2025 | Time not confirmed | -0.43 | -0.42 | +2.3% |
| Mar 27, 2025 | After the close | -0.51 | -0.54 | -5.9% |
| Nov 7, 2024 | After the close | -0.56 | -0.42 | +25.0% |
| Aug 8, 2024 | After the close | -0.55 | -0.46 | +16.4% |
| May 9, 2024 | After the close | -0.43 | -0.51 | -18.6% |
| Mar 18, 2024 | After the close | -0.40 | -0.39 | +2.5% |
| Nov 8, 2023 | After the close | -0.48 | -0.29 | +39.6% |
| Aug 9, 2023 | After the close | -0.45 | -0.44 |
Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1a clinical trial for the treatment of advanced or metastatic solid tumors, or unresectable or recurrent GBM, solid tumor, such as…
| +2.2% |
| May 9, 2023 | After the close | -0.48 | -0.36 | +25.0% |
| Mar 20, 2023 | After the close | -0.47 | -0.31 | +34.0% |
| Nov 7, 2022 | After the close | -0.48 | -0.21 | +56.3% |
| Aug 8, 2022 | After the close | -0.52 | -0.41 | +21.2% |
| May 3, 2022 | After the close | -0.29 | -0.38 | -31.0% |
| Mar 10, 2022 | After the close | -0.40 | -0.32 | +20.0% |
| Nov 1, 2021 | After the close | -0.24 | -0.36 | -50.0% |
| Jul 29, 2021 | After the close | -0.26 | -0.21 | +19.2% |
| May 3, 2021 | After the close | -0.27 | -0.24 | +11.1% |
| Mar 10, 2021 | After the close | -0.45 | -0.47 | -4.4% |
| Oct 29, 2020 | After the close | -0.35 | -0.27 | +22.9% |
| Jul 30, 2020 | Before the open | -0.37 | -0.31 | +16.2% |
| Jun 12, 2020 | After the close | 0.00 | -0.40 | — |